Product Image

Omega-3 Delicious Lemon Meringue

Natural Factors SeaRich
4.8
★ ★ ★ ★ ★
(171 ratings)
EPA (Eicosapentaenoic Acid) 750 mg
Omega-3 1390 mg
Fish Oil 4370 mg
DHA 500 mg
Product Image
Score84
A flavored liquid supplies meaningful EPA and DHA from named small fish. Moderate concentration and missing form, oxidation, and purity details temper its otherwise useful dose.
How scoring works
Quantity:6 Fluid Ounce(s) • (40 servings)
Goals:
Heart Health
Anti-Inflammatory Support
Cardiovascular Support
Vision Support
Metabolism Boost
Skin Health
Joint Health
Mental Focus

Score 84

A flavored liquid supplies meaningful EPA and DHA from named small fish. Moderate concentration and missing form, oxidation, and purity details temper its otherwise useful dose.
How scoring works
$18.00($0.45 per serving)
Vitacost
$ 19.83
iHerb
$ 18.00
Report prices

Analysis

A serving delivers 750 mg of EPA and 500 mg of DHA within 1,390 mg of total omega-3 fats. The amount supports broad cardiovascular, inflammatory, vision, and skin-related pathways without being overwhelmingly EPA-heavy.

Anchovy, mackerel, and sardine sources improve traceability, and the lemon-meringue liquid may suit users who dislike capsules. The serving also contains 4.37 g of fish oil, showing only moderate concentration, and form and oxidation controls are not stated.

The product suits adults who want a substantial liquid dose with both EPA and DHA. Precise measuring is required, and shoppers who prioritize a concentrated or independently verified oil may want more documentation.

Who is it for
  • Adults who prefer flavored liquid fish oil
  • Users seeking both EPA and DHA
  • People who value named small-fish sources
Best for
  • Broad omega-3 support
  • Users who dislike softgels
  • Balanced EPA and DHA intake

Pros

  • Provides 750 mg EPA and 500 mg DHA
  • Names anchovy, mackerel, and sardine sources
  • Liquid format avoids capsules
  • Competitive active efficiency

Cons

  • Oil is only moderately concentrated
  • Molecular form is not stated
  • No antioxidant protection is listed
  • Independent purity verification is absent
  • Requires liquid measurement

Warnings

  • Contains fish oil and is not suitable for people with a fish allergy
  • Fish oil may cause fishy aftertaste, reflux, or digestive discomfort in sensitive users
  • The substantial EPA and DHA amount may be relevant for people using anticoagulant or antiplatelet medicines

Nutrient quality

87 Highest impact

Anchovy, mackerel, and sardine oil in a flavored liquid with an unspecified molecular form gives the formula reasonable ingredient quality. The disclosed amounts are meaningful and the ingredient selection stays focused.

Ingredient transparency

87 Highest impact

The meaningful actives and their amounts are clearly identified. Serving guidance and the complete inactive-ingredient list are not fully supplied.

Customer satisfaction

65 Moderate impact

The aggregate rating is strong but the review volume limits confidence. No review excerpts are supplied to assess repeated complaints or purpose-specific experiences.

Value for money

91 Highest impact

Formula quality provides fair value for the category. The effective serving and focused ingredient list compare favorably with similar options.

Report analysis

Goals

Heart Health
Heart Health
Impact
Highest effect
A Goal FitA+ Strength of SupportC+ CoverageA+ Formula Quality
EPA (Eicosapentaenoic Acid) · 750 mg

Clearly disclosed EPA and DHA provide direct support for triglyceride management and cardiovascular inflammation. The combined amount is substantial enough to make this a focused and evidence-based heart-health option.

The formula concentrates on one major lipid pathway rather than vascular tone, cardiac energy, or homocysteine support. EPA and DHA can increase bleeding tendency when combined with anticoagulants or antiplatelet medicines, especially at higher total daily omega-3 intakes.

Study evidence
Anti-Inflammatory Support
Anti-Inflammatory Support
Impact
Highest effect
A Goal FitA Strength of SupportC CoverageA+ Formula Quality
Fish Oil · 4370 mg

EPA and DHA provide strong evidence for inflammation-resolving lipid pathways, and their combined amount exceeds the stated minimum. EPA is especially prominent while DHA adds complementary membrane and mediator support.

The liquid fish oil clearly states both active fatty acids and source species. The focused formula offers strong depth in one major pathway without unrelated additions.

Study evidence
Fish Oil Supportive 68 studies
Cardiovascular Support
Cardiovascular Support
Impact
Highest effect
A+ Goal FitB Strength of SupportB CoverageA+ Formula Quality
Fish Oil · 4370 mg

EPA and DHA provide strong, direct support for triglycerides, endothelial function, and inflammatory balance. The combined active amount is meaningful for general cardiovascular use.

Separate EPA and DHA disclosure and named small-fish sources make the serving easy to assess. Molecular form, purification testing, and antioxidant protection are not stated, which leaves some quality uncertainty.

Vision Support
Vision Support
Impact
Highest effect
A- Goal FitA Strength of SupportC+ CoverageA+ Formula Quality
EPA (Eicosapentaenoic Acid) · 750 mg

High EPA and DHA amounts provide strong support for ocular-surface balance and retinal membrane structure. DHA is especially relevant to the retina, while EPA complements it through surface and inflammatory signaling pathways.

Fish sources and individual fatty-acid weights are disclosed, though the triglyceride or ethyl-ester form is not. The focused liquid formula has good depth but no macular carotenoids or antioxidant minerals.

Study evidence
Metabolism Boost
Metabolism Boost
Impact
Highest effect
B Goal FitA- Strength of SupportC+ CoverageA Formula Quality
Omega-3 · 1390 mg

Omega-3 fatty acids support insulin signaling, cell-membrane function, and metabolic health through reduced inflammatory strain. The 1390 mg serving is substantial, but the effect is supportive rather than a direct increase in thermogenesis.

EPA and DHA amounts and fish species are transparent, while molecular form, purification, and independent testing remain undisclosed. No stimulant, thyroid nutrient, or mitochondrial transport active is included, so pathway coverage remains moderate.

Study evidence
Omega-3 Supportive 42 studies
Skin Health
Skin Health
Impact
Highest effect
B+ Goal FitB Strength of SupportB- CoverageA- Formula Quality
Omega-3 · 1390 mg

The disclosed EPA and DHA amount provides substantial support for skin-barrier lipids and inflammatory balance. Named small-fish sources improve source clarity.

The molecular form is not identified, which limits confidence in absorption. Antioxidant protection and independent purity verification are also absent from the supplied data.

Study evidence
Omega-3 Supportive 35 studies

Ingredients

IngredientAmount per serving
Calories
40 Calorie(s)
Total Fat
4.5 Gram(s)
Saturated Fat
1.5 Gram(s)
Polyunsaturated Fat
2 Gram(s)
Cholesterol
25 mg
Fish Oil
4370 mg
Omega-3 Fatty Acids
1390 mg
Eicosapentaenoic Acid
750 mg
Docosahexaenoic Acid
500 mg
Gluten Free Adults 18–50 Dairy Free Sugar Free
Report overview
EPA (Eicosapentaenoic Acid) · 750 mg OverallScore56
F Active Ingredient Quality & BioavailabilityB- Dose, Safety & Label TransparencyB+ Value

The molecular form is unspecified; ePA density is low, and no protective antioxidant is listed. The serving provides a strong EPA amount with a clearly EPA-centric ratio. No purification or third-party verification is shown, while normalized cost is favorable.

View ingredientView products
Omega-3 · 1390 mg OverallScore52
F Active Ingredient Quality & BioavailabilityC- Dose, Safety & Label TransparencyA+ Value

EPA and DHA are clearly disclosed, but they form a relatively small share of the total fish oil. Small-fish sources are identified, while molecular form, antioxidant protection, and independent purity testing are absent. The low serving cost provides excellent value per combined EPA and DHA amount.

View ingredientView products
Fish Oil · 4370 mg OverallScore50
F Active Ingredient Quality & BioavailabilityC Dose, Safety & Label TransparencyA+ Value

Named small-fish sources are a strength, but molecular form and purification are not disclosed. The EPA and DHA dose is effective and transparent, although the oil is weakly concentrated. Cost efficiency is excellent, while antioxidant protection is not shown.

View ingredientView products
Loading alternative details
86 Performance

Omega-3 Triglyceride Fish Oil 1100 mg

NATURELO Premium Supplements
A stronger supplied quality profile than Omega-3 Delicious Lemon Meringue is supported by a highly concentrated 1,100 mg triglyceride omega-3 serving with clear EPA and DHA amounts. Molecular distillation adds purity assurance, though fish species, antioxidant protection, and independent testing are not stated.
86 Performance

Purified & Clear Omega 3 Fish Oil 1000 mg

Doctor's Best
A stronger supplied quality profile than Omega-3 Delicious Lemon Meringue is supported by a substantial serving with EPA and DHA stated separately. The ethyl-ester form is less readily absorbed than triglyceride oil, and oxidation protection plus independent testing are not supplied.
85 Performance

Wild Alaskan Fish Oil Peak EPA

Wiley's Finest
A stronger supplied quality profile than Omega-3 Delicious Lemon Meringue is supported by a concentrated EPA-heavy serving with individual fatty-acid amounts clearly stated. Molecular form, oxidation protection, purification, and independent testing remain unspecified.
79 Budget

Fish Oil 1000 mg

Mason Natural
Lower recurring cost is the clearest advantage over Omega-3 Delicious Lemon Meringue, while the formula provides clearly disclosed EPA and DHA in a basic 1,000 mg fish-oil softgel. The active omega-fat amount is low, and source, molecular form, oxidation protection, and purity testing are not supplied.
82 Budget

Omega 3 Fish Oil Concentrate

Solgar
Lower recurring cost is the clearest advantage over Omega-3 Delicious Lemon Meringue, while the formula provides a modest, clearly disclosed EPA and DHA serving for routine use. Low concentration plus missing molecular-form, source, oxidation, and purity details limit quality confidence.
69 Budget

Kid's Chewable DHA 100 mg Bursting Orange Flavor!

Carlson
Lower recurring cost is the clearest advantage over Omega-3 Delicious Lemon Meringue, while the formula provides triglyceride fish oil and vitamin E in a child-friendly chewable with 100 mg DHA. The active omega-3 amount and oil concentration are low, and independent purity testing is not supplied.
84 Value

Omega-3 Fish Oil 1250 mg

SR Sports Research
Lower recurring cost paired with a highly concentrated EPA-led fish-oil serving in one softgel creates a useful value trade-off versus Omega-3 Delicious Lemon Meringue. Molecular form, purification, antioxidant protection, fish species, and independent testing are not supplied.
84 Value

Fish Oil 1400 mg

Nature's Bounty
Lower recurring cost paired with a meaningful EPA-led amount with strong oil concentration creates a useful value trade-off versus Omega-3 Delicious Lemon Meringue. The ethyl-ester form is less readily absorbed, and fish source, antioxidant protection, and independent testing are not stated.
82 Value

Triple Strength Omega-3

InnovixLabs
Lower recurring cost paired with a concentrated mix of EPA, DHA, DPA, and other omega-3 fats in a long supply creates a useful value trade-off versus Omega-3 Delicious Lemon Meringue. Molecular form, purification, fish species, antioxidant protection, and independent testing are missing, and one label row is malformed.
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Omega-3 fatty acid supplement skin cancer prophylaxis in lung transplant recipients: A randomized, controlled pilot trial.
    Miura K; Vail A; Chambers D; Hopkins PM; Ferguson L; Grant M; Rhodes LE; Green AC · The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2019
    Randomized trial49 participantsSkin Health forOmega-3
  2. Prenatal Omega-3 Supplementation and Eczema Risk among Offspring at Age 36 Months.
    Berman D; Clinton C; Limb R; Somers EC; Romero V; Mozurkewich E · Insights in allergy, asthma & bronchitis · 2020
    Randomized trial84 participantsSkin Health forOmega-3
  3. Dose-dependent effects of fish oil on cardio-metabolic biomarkers in healthy middle-aged and elderly Chinese people: a double-blind randomized controlled trial.
    Song J; Hu M; Li C; Yang B; Ding Q; Wang C; Mao L · Food & function · 2018
    Randomized trial201 participantsAnti-Inflammatory Support forFish Oil
  4. Eicosapentaenoic acid supplementation alleviates pruritus, enhances skin moisture, and mitigates depression in maintenance hemodialysis patients.
    Lin YL; Wang CL; Chiang TI · Frontiers in nephrology · 2024
    Randomized trial60 participantsAnti-Inflammatory Support forFish Oil
  5. Lowering effects of fish oil supplementation on proinflammatory markers in hypertension: results from a randomized controlled trial.
    Yang B; Ren XL; Li ZH; Shi MQ; Ding F; Su KP; Guo XJ; Li D · Food & function · 2020
    Randomized trial77 participantsAnti-Inflammatory Support forFish Oil
  6. The effects of ω-3 fish oil emulsion-based parenteral nutrition plus combination treatment for acute paraquat poisoning.
    Meng Z; Dong Y; Gao H; Yao D; Gong Y; Meng Q; Zheng T; Cui X; Su X; Tian Y · The Journal of international medical research · 2019
    Randomized trial174 participantsAnti-Inflammatory Support forFish Oil
  7. Effects of Omega-3 Fatty Acid Intake in Patients Undergoing Dialysis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Liu R; Jiang J; Fu Z; Liu C; Yao L; Quan H · Journal of the American Nutrition Association · 2022
    Meta-analysis49 studies pooledAnti-Inflammatory Support forFish Oil
  8. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis.
    Yokoyama M; Origasa H; Matsuzaki M; Matsuzawa Y; Saito Y; Ishikawa Y; Oikawa S; Sasaki J; Hishida H; Itakura H; Kita T; Kitabatake A; Nakaya N; Sakata T; Shimada K; Shirato K; Japan EPA lipid intervention study (JELIS) Investigators · Lancet (London, England) · 2007
    Randomized trial18,645 participantsHeart Health forEPA (Eicosapentaenoic Acid)
  9. Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS).
    Saito Y; Yokoyama M; Origasa H; Matsuzaki M; Matsuzawa Y; Ishikawa Y; Oikawa S; Sasaki J; Hishida H; Itakura H; Kita T; Kitabatake A; Nakaya N; Sakata T; Shimada K; Shirato K; JELIS Investigators, Japan · Atherosclerosis · 2008
    Randomized trial14,981 participantsHeart Health forEPA (Eicosapentaenoic Acid)
  10. Effects of omega-3 fatty acids on coronary revascularization and cardiovascular events: a meta-analysis.
    Dinu M; Sofi F; Lotti S; Colombini B; Mattioli AV; Catapano AL; Casula M; Baragetti A; Wong ND; Steg PG; Ambrosio G · European journal of preventive cardiology · 2024
    Meta-analysis134,144 participants18 studies pooledHeart Health forEPA (Eicosapentaenoic Acid)
  11. Incremental effects of eicosapentaenoic acid on cardiovascular events in statin-treated patients with coronary artery disease.
    Matsuzaki M; Yokoyama M; Saito Y; Origasa H; Ishikawa Y; Oikawa S; Sasaki J; Hishida H; Itakura H; Kita T; Kitabatake A; Nakaya N; Sakata T; Shimada K; Shirato K; Matsuzawa Y; JELIS Investigators · Circulation journal : official journal of the Japanese Circulation Society · 2009
    Randomized trialHeart Health forEPA (Eicosapentaenoic Acid)
  12. Omega-3 Fatty Acids for the Management of Hypertriglyceridemia: A Science Advisory From the American Heart Association.
    Skulas-Ray AC; Wilson PWF; Harris WS; Brinton EA; Kris-Etherton PM; Richter CK; Jacobson TA; Engler MB; Miller M; Robinson JG; Blum CB; Rodriguez-Leyva D; de Ferranti SD; Welty FK; American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Lifestyle and Cardiometabolic Health; Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; and Council on Clinical Cardiology · Circulation · 2020
    OtherHeart Health forEPA (Eicosapentaenoic Acid)
  13. Supplementation of fish oil and olive oil in patients with rheumatoid arthritis.
    Berbert AA; Kondo CR; Almendra CL; Matsuo T; Dichi I · Nutrition (Burbank, Los Angeles County, Calif.) · 2005
    Randomized trial43 participantsJoint Health forOmega-3
  14. Krill oil improved osteoarthritic knee pain in adults with mild to moderate knee osteoarthritis: a 6-month multicenter, randomized, double-blind, placebo-controlled trial.
    Stonehouse W; Benassi-Evans B; Bednarz J; Vincent AD; Hall S; Hill CL · The American journal of clinical nutrition · 2022
    Randomized trial235 participantsJoint Health forOmega-3
  15. Effects of omega-3 supplementation on lipid metabolism, inflammation, and disease activity in rheumatoid arthritis: a meta-analysis of randomized controlled trials.
    Wang W; Xu Y; Zhou J; Zang Y · Clinical rheumatology · 2024
    Meta-analysis1,018 participants18 studies pooledJoint Health forOmega-3
  16. Impact of type and dose of oral polyunsaturated fatty acid supplementation on disease activity in inflammatory rheumatic diseases: a systematic literature review and meta-analysis.
    Sigaux J; Mathieu S; Nguyen Y; Sanchez P; Letarouilly JG; Soubrier M; Czernichow S; Flipo RM; Sellam J; Daïen C · Arthritis research & therapy · 2022
    Meta-analysis1,420 participants30 studies pooledJoint Health forOmega-3
  17. A meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain.
    Goldberg RJ; Katz J · Pain · 2007
    Meta-analysis17 studies pooledJoint Health forOmega-3
  18. The influence of n-3 polyunsaturated fatty acids on cognitive function in individuals without dementia: a systematic review and dose-response meta-analysis.
    Suh SW; Lim E; Burm SY; Lee H; Bae JB; Han JW; Kim KW · BMC medicine · 2024
    Meta-analysis9,660 participants24 studies pooledMental Focus forEPA (Eicosapentaenoic Acid)
  19. EPA supplementation improves teacher-rated behaviour and oppositional symptoms in children with ADHD.
    Gustafsson PA; Birberg-Thornberg U; Duchén K; Landgren M; Malmberg K; Pelling H; Strandvik B; Karlsson T · Acta paediatrica (Oslo, Norway : 1992) · 2011
    Randomized trial92 participantsMental Focus forEPA (Eicosapentaenoic Acid)
  20. Docosahexaenoic Acid (DHA) and Eicosapentaenoic Acid (EPA)-Should They Be Mandatory Supplements in Pregnancy?
    Amza M; Haj Hamoud B; Sima RM; Dinu MD; Gorecki GP; Popescu M; Gică N; Poenaru MO; Pleș L · Biomedicines · 2024
    Narrative reviewMental Focus forEPA (Eicosapentaenoic Acid)
  21. Supplementation with oil rich in eicosapentaenoic acid, but not in docosahexaenoic acid, improves global cognitive function in healthy, young adults: results from randomized controlled trials.
    Patan MJ; Kennedy DO; Husberg C; Hustvedt SO; Calder PC; Khan J; Forster J; Jackson PA · The American journal of clinical nutrition · 2021
    Randomized trial310 participantsMental Focus forEPA (Eicosapentaenoic Acid)
  22. Effects of omega-3 supplementation on glucose and lipid metabolism in patients with gestational diabetes: A meta-analysis of randomized controlled trials.
    Liu W; Gao M; Yang S; Sun C; Bi Y; Li Y; Wang J; Yuan X · Journal of diabetes and its complications · 2023
    Meta-analysis331 participants6 studies pooledMetabolism Boost forOmega-3
  23. Hepatic de novo lipogenesis is suppressed and fat oxidation is increased by omega-3 fatty acids at the expense of glucose metabolism.
    Green CJ; Pramfalk C; Charlton CA; Gunn PJ; Cornfield T; Pavlides M; Karpe F; Hodson L · BMJ open diabetes research & care · 2021
    Randomized trial38 participantsMetabolism Boost forOmega-3
  24. Clinical and metabolic response to flaxseed oil omega-3 fatty acids supplementation in patients with diabetic foot ulcer: A randomized, double-blind, placebo-controlled trial.
    Soleimani Z; Hashemdokht F; Bahmani F; Taghizadeh M; Memarzadeh MR; Asemi Z · Journal of diabetes and its complications · 2018
    Randomized trial60 participantsMetabolism Boost Skin Health forOmega-3
  25. The Effects of Flaxseed Oil Omega-3 Fatty Acids Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Mirmasoumi G; Fazilati M; Foroozanfard F; Vahedpoor Z; Mahmoodi S; Taghizadeh M; Esfeh NK; Mohseni M; Karbassizadeh H; Asemi Z · Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association · 2018
    Randomized trial60 participantsMetabolism Boost forOmega-3
  26. A combination of omega-3 and plant sterols regulate glucose and lipid metabolism in individuals with impaired glucose regulation: a randomized and controlled clinical trial.
    Wang JF; Zhang HM; Li YY; Xia S; Wei Y; Yang L; Wang D; Ye JJ; Li HX; Yuan J; Pan RR · Lipids in health and disease · 2019
    Randomized trial200 participantsMetabolism Boost forOmega-3
  27. Dietetic intervention in psoriatic arthritis: the DIETA trial.
    Leite BF; Morimoto MA; Gomes CMF; Klemz BNC; Genaro PS; Shivappa N; Hébert JR; Damasceno NRT; Pinheiro MM · Advances in rheumatology (London, England) · 2022
    Randomized trial97 participantsSkin Health forOmega-3
  28. Treatment of hard-to-heal wounds in ischaemic lower extremities with a novel fish skin-derived matrix.
    Lee YJ; Han HJ; Shim HS · Journal of wound care · 2024
    Randomized trial50 participantsSkin Health forOmega-3
  29. Effect of eicosapentaenoic acid, an omega-3 polyunsaturated fatty acid, on UVR-related cancer risk in humans. An assessment of early genotoxic markers.
    Rhodes LE; Shahbakhti H; Azurdia RM; Moison RM; Steenwinkel MJ; Homburg MI; Dean MP; McArdle F; Beijersbergen van Henegouwen GM; Epe B; Vink AA · Carcinogenesis · 2003
    Randomized trial42 participantsSkin Health forOmega-3
  30. Dietary omega-3 LCPUFA intake in the prevention of neovascular age-related macular degeneration: a systematic review and meta-analysis.
    Meng XT; Shi YY; Hong-Yan Z · Nutricion hospitalaria · 2022
    Meta-analysis5 studies pooledVision Support forEPA (Eicosapentaenoic Acid)
  31. Dietary omega-3 polyunsaturated fatty acids and fish intake and risk of age-related macular degeneration.
    Jiang H; Shi X; Fan Y; Wang D; Li B; Zhou J; Pei C; Ma L · Clinical nutrition (Edinburgh, Scotland) · 2022
    Meta-analysis21 studies pooledVision Support forEPA (Eicosapentaenoic Acid)
  32. Dietary fatty acid intake, plasma fatty acid levels, and the risk of age-related macular degeneration (AMD): a dose-response meta-analysis of prospective cohort studies.
    Zhong Y; Wang K; Jiang L; Wang J; Zhang X; Xu J; Yao K · European journal of nutrition · 2021
    Meta-analysis167,581 participants11 studies pooledVision Support forEPA (Eicosapentaenoic Acid)
  33. Dietary ω-3 fatty acid and fish intake and incident age-related macular degeneration in women.
    Christen WG; Schaumberg DA; Glynn RJ; Buring JE · Archives of ophthalmology (Chicago, Ill. : 1960) · 2011
    Cohort study38,022 participantsVision Support forEPA (Eicosapentaenoic Acid)
  34. Can Omega-3 Fatty Acids Serve as a Preventive Strategy for Age-Related Macular Degeneration? A Systematic Review and Meta-Analysis.
    Chen KY; Chan HC; Chan CM · The Journal of nutrition · 2026
    Meta-analysis18 studies pooledVision Support forEPA (Eicosapentaenoic Acid)